Decreased Cardiovascular Mortality in Patients with Incident Rheumatoid Arthritis (RA) in Recent Years: Dawn of a New Era in Cardiovascular Disease in RA?
- PMID: 28365576
- PMCID: PMC5457313
- DOI: 10.3899/jrheum.161154
Decreased Cardiovascular Mortality in Patients with Incident Rheumatoid Arthritis (RA) in Recent Years: Dawn of a New Era in Cardiovascular Disease in RA?
Abstract
Objective: To assess trends in cardiovascular (CV) mortality in patients with incident rheumatoid arthritis (RA) in 2000-07 versus the previous decades, compared with non-RA subjects.
Methods: The study population consisted of Olmsted County, Minnesota, USA residents with incident RA (age ≥ 18 yrs, 1987 American College of Rheumatology criteria was met in 1980-2007) and non-RA subjects from the same underlying population with similar age, sex, and calendar year of index. All subjects were followed until death, migration, or December 31, 2014. Followup was truncated for comparability. Aalen-Johansen methods were used to estimate CV mortality rates, adjusting for competing risk of other causes. Cox proportional hazards models were used to compare CV mortality by decade.
Results: The study included 813 patients with RA and 813 non-RA subjects (mean age 55.9 yrs; 68% women for both groups). Patients with incident RA in 2000-07 had markedly lower 10-year overall CV mortality (2.7%, 95% CI 0.6-4.9%) and coronary heart disease (CHD) mortality (1.1%, 95% CI 0.0-2.7%) than patients diagnosed in 1990-99 (7.1%, 95% CI 3.9-10.1% and 4.5%, 95% CI 1.9-7.1%, respectively; HR for overall CV death: 0.43, 95% CI 0.19-0.94; CHD death: HR 0.21, 95% CI 0.05-0.95). This improvement in CV mortality persisted after accounting for CV risk factors. Ten-year overall CV mortality and CHD mortality in 2000-07 RA incidence cohort was similar to non-RA subjects (p = 0.95 and p = 0.79, respectively).
Conclusion: Our findings suggest significantly improved overall CV mortality, particularly CHD mortality, in patients with RA in recent years. Further studies are needed to examine the reasons for this improvement.
Keywords: CARDIOVASCULAR DISEASE; CORONARY HEART DISEASE; MORTALITY; RHEUMATOID ARTHRITIS.
Figures


Similar articles
-
Improved Incidence of Cardiovascular Disease in Patients With Incident Rheumatoid Arthritis in the 2000s: A Population-based Cohort Study.J Rheumatol. 2021 Sep;48(9):1379-1387. doi: 10.3899/jrheum.200842. Epub 2021 Feb 15. J Rheumatol. 2021. PMID: 33589553 Free PMC article.
-
Longterm blood pressure variability in patients with rheumatoid arthritis and its effect on cardiovascular events and all-cause mortality in RA: a population-based comparative cohort study.J Rheumatol. 2014 Aug;41(8):1638-44. doi: 10.3899/jrheum.131170. Epub 2014 Jul 1. J Rheumatol. 2014. PMID: 24986852 Free PMC article.
-
Trends in Incidence of Chronic Heart Failure in Patients With Rheumatoid Arthritis: A Population-Based Study Validating Different Heart Failure Definitions.J Rheumatol. 2023 Jul;50(7):881-888. doi: 10.3899/jrheum.221170. Epub 2023 Mar 15. J Rheumatol. 2023. PMID: 36921969 Free PMC article.
-
Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.Arthritis Rheum. 2005 Feb;52(2):402-11. doi: 10.1002/art.20853. Arthritis Rheum. 2005. PMID: 15693010 Review.
-
Cardiovascular case fatality in rheumatoid arthritis is decreasing; first prospective analysis of a current low disease activity rheumatoid arthritis cohort and review of the literature.BMC Musculoskelet Disord. 2014 Apr 29;15:142. doi: 10.1186/1471-2474-15-142. BMC Musculoskelet Disord. 2014. PMID: 24779371 Free PMC article. Review.
Cited by
-
Cardiovascular Disease Risk in Older Adults and Elderly Patients with Rheumatoid Arthritis: What Role Can Disease-Modifying Antirheumatic Drugs Play in Cardiovascular Risk Reduction?Drugs Aging. 2019 Jun;36(6):493-510. doi: 10.1007/s40266-019-00653-0. Drugs Aging. 2019. PMID: 30953327 Review.
-
Cardiovascular risk management in rheumatoid and psoriatic arthritis: online survey results from a national cohort study.BMC Rheumatol. 2018 Sep 6;2:25. doi: 10.1186/s41927-018-0032-9. eCollection 2018. BMC Rheumatol. 2018. PMID: 30886975 Free PMC article.
-
Crosstalk between Inflammation and Atherosclerosis in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Is There a Common Basis?Life (Basel). 2024 May 31;14(6):716. doi: 10.3390/life14060716. Life (Basel). 2024. PMID: 38929699 Free PMC article. Review.
-
Is Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis Still a More Severe Disease Than Anti-Citrullinated Protein Antibody-Negative Rheumatoid Arthritis? A Longitudinal Cohort Study in Rheumatoid Arthritis Patients Diagnosed From 2000 Onward.Arthritis Care Res (Hoboken). 2018 Jul;70(7):987-996. doi: 10.1002/acr.23497. Epub 2018 May 28. Arthritis Care Res (Hoboken). 2018. PMID: 29266813 Free PMC article.
-
Long-term outcomes in Rheumatoid Arthritis: Review of data from the 'Basildon Inflammatory Arthritis Cohort'.Rheumatol Adv Pract. 2022 Sep 5;6(3):rkac075. doi: 10.1093/rap/rkac075. eCollection 2022. Rheumatol Adv Pract. 2022. PMID: 36176320 Free PMC article.
References
-
- Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008;59:1690–7. - PubMed
-
- Wolfe F, Michaud K. The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis. Arthritis Rheum. 2008;58:2612–21. - PubMed
-
- Masuda H, Miyazaki T, Shimada K, Tamura N, Matsudaira R, Yoshihara T, et al. Disease duration and severity impacts on long-term cardiovascular events in Japanese patients with rheumatoid arthritis. J Cardiol. 2014;64:366–70. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous